Nitric oxide synthase inhibition modulates the ventilatory depressant and antinociceptive actions of fourth ventricular infusions of morphine in the awake dog

Anesthesiology

Volumn 85, Issue 6, 1996, Pages 1367-1377

  Pelligrino, Dale A ^a   Laurito, Charles E ^b   Vadeboncouer, Timothy P ^b  

^a MICHAEL REESE HOSPITAL   (United States)

^b NONE

Author keywords

Analgesia: morphine; Brain: cisterna magna; fourth ventricle; Nitric oxide; nitro L arginine: S nitroso acetylpenicillamine; Ventilation: carbon dioxide response

Indexed keywords

MORPHINE SULFATE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BRAIN FOURTH VENTRICLE; CISTERNA MAGNA; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG MIXTURE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATION CONTROL; RESPIRATION DEPRESSION;

ANALGESIA, EPIDURAL; ANALGESICS, OPIOID; ANIMALS; DOGS; ENZYME INHIBITORS; MALE; MORPHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PAIN THRESHOLD; PENICILLAMINE; RESPIRATION; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 0030443809     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199612000-00018     Document Type: Article

References (50)

1. Pelligrino DA, Peterson RD, Henderson SK, Albrecht RF: Comparative ventilatory effects of intravenous versus fourth cerebroventricular infusions of morphine sulfate in the unanesthetized dog. ANESTHESIOLOGY 1989; 71:250-9
2. Xu JY, Tseng LF: Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse. J Pharmacol Exp Ther 1995; 274:8-16
3. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 1994; 14:175-92
4. Garthwaite J: Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991; 14:60-7
5. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 1991; 102:198-202
6. Meller ST, Lewis SJ, Bates JN, Brody MJ, Gebhart GF: Is there a role for an endothelium-derived relaxing factor in nociception? Brain Res 1990; 531:342-5
7. Kawabata A, Umeda N, Takagi H: L-arginine exerts a dual role in nociceptive processing in the brain - Involvement of the kyotorphinmet-enkephalin pathway and NO-cyclic GMP pathway. Br J Pharmacol 1993; 109:73-9
8. Ji XQ, Zhu XZ: Possible involvement of nitric oxide in arginine- induced analgesia. Acta Pharmacol Sin 1993; 14:289-91
9. Przewlocki R, Machelska H, Przewlocka B: Modulation of morphine and cocaine effects by inhibition of nitric oxide synthase. Regul Pept 1994; 54:233-5
10. Haxhiu MA, Chang CH, Dreshaj LA, Erokwu B, Prabhakar NR, Cherniack NS: Nitric oxide and ventilatory response to hypoxia. Resp Physiol 1995; 101:257-66
11. Ling L, Karius D, Fiscus R, Speck D: Endogenous nitric oxide required for an integrative respiratory function in the cat brain. J Neurophysiol 1992; 68:1910-2
12. Xu JY, Tseng LF: Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse. Eur J Pharmacol 1994; 262:223-31
13. Przewocki R, Machelska H, Przewocka B: Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci 1993; 53:PL1-PL5
14. Malmberg AB, Yaksh TL: Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces anti- nociception in the formalin test in rats. Pain 1993; 54:291-300
15. Meller ST, Cummings CP, Traub RJ, Gebhart GF: The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 1994; 60:367-74
16. Iwamoto ET, Marion L: Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. J Pharmacol Exp Ther 1994; 269:699-708
17. Semos ML, Headley PM: The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation. Neuropharmacology 1994; 33:1487-97
18. Guevaraguzman R, Emson PC, Kendrick KM: Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J Neurochem 1994; 62:807-10
19. Lawrence AJ, Jarrott B: Nitric oxide increases interstitial excit- atory amino acid release in the rat dorsomedial medulla oblongata. Neurosci Lett 1993; 151:126-9
20. Lonart G, Wang J, Johnson KM: Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol 1992; 220:271-2
21. Burton M, Johnson D, Kazemi H: Adrenergic and cholinergic interaction in central ventilatory control. J Appl Physiol 1990; 68:2092-9
22. Pierrefiche O, Schmid K, Foutz A, Denavit Saubie M: Endogenous activation of NMDA and non-NMDA glutamate receptors on respiratory neurones in cat medulla. Neuropharmacology 1991; 30:429-40
23. B receptor agonists and antagonists on the bulbar respiratory network in cat. Brain Res 1993; 605:77-84
24. Kamisaki Y, Wada K, Nakamoto K, Itoh T: Nitric oxide inhibition of the depolarization-evoked glutamate release from synaptosomes of rat cerebellum. Neurosci Lett 1995; 194:5-8
25. Pogun S, Dawson V, Kuhar MJ: Nitric oxide inhibits H-3-glutamate transport in synaptosomes. Synapse 1994; 18:21-6
26. Dev KK, Morris BJ: Modulation of alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid (AMPA) binding sites by nitric oxide. J Neurochem 1994; 63:946-52
27. Manzoni O, Bockaert J: Nitric oxide synthase activity endogenously modulates NMDA receptors. J Neurochem 1993; 61:368-70
28. Luo D, Vincent SR: NMDA-dependent nitric oxide release in the hippocampus in vivo: Interactions with noradrenaline. Neuropharmacology 1994; 33:1345-50
29. Lonart G, Johnson KM: Characterization of nitric oxide generator-induced hippocampal [H-3]norepinephrine release. 2. The role of calcium, reverse norepinephrine transport and cyclic 3′,5′-guanosine monophosphate. J Pharmacol Exp Ther 1995; 275:14-22
30. Kneussl M, Pappagianopoulos P, Hoop B, Kazemi H: Reversible depression of ventilation and cardiovascular function by ventriculocisternal perfusion with gamma-aminobutyric acid in dogs. Am Rev Respir Dis 1986; 133:1024-8
31. Segovia G, Porras A, Mora F: Effects of a nitric oxide donor on glutamate and GABA release in striatum and hippocampus of the conscious rat. NeuroReport 1994; 5:1937-40
32. Ma S, Long J: Central noradrenergic activity is responsible for nitroglycerin-induced cardiovascular effects in the nucleus tractus solitarii. Brain Res 1991; 559:297-303
33. Valtschanoff J, Weinberg R, Rustioni A, Schmidt H: Colocalization of neuronal nitric oxide synthase with GABA in rat cuneate nucleus. J Neurocytol 1995; 24:237-45
34. Ohta A, Takagi H, Matsui T, Hamai Y, Iida S, Esumi H: Localization of nitric oxide synthase-immunoreactive neurons in the solitary nucleus and ventrolateral medulla-oblongata of the rat - Their relation to catecholaminergic neurons. Neurosci Lett 1993; 158:33-5
35. Maqbool A, Batten TFC, Mcwilliam PN: Co-localization of neurotransmitter immunoreactivities in putative nitric oxide synthesizing neurones of the cat brain stem. J Chem Neuroanat 1995; 8:191-206
36. Bloss J, Hammond D: Intermittent shock titration task in the rhesus monkey and its validity as an analgesiometric procedure. Brain Res 1989; 499:344-56
37. Vierck C, Jr., Lee C, Willcockson H, Kitzmiller A, Bullitt E, Light A: Effects of anterolateral spinal lesions on escape responses of rats to hindpaw stimulation. Somatosens Motor Res 1995; 12:163- 74
38. Lautenbacher S, Rollman G: Sex differences in responsiveness to painful and non-painful stimuli are dependent upon the stimulation method. Pain 1993; 53-255-64
39. Andersen O, Jensen L, Brennum J, Arendt Nielsen L: Evidence for central summation of C and A delta nociceptive activity in man. Pain 1994; 59:273-80
40. Brignola G, Calignano A, Dirosa M: Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol 1994; 113:1372-6
41. Xu JY, Tseng LF: Increase of nitric oxide by L-arginine potentiates beta-endorphin-but not mu-, delta- or kappa-opioid agonist-induced antinociception in the mouse. Eur J Pharmacol 1993; 236:137- 42
42. Kolesnikov Y, Jain S, Pasternak GW: Modulation of opioid analgesia by agmatine. Eur J Pharmacol 1996; 296:17-22
43. Xu ZM, Li P, Tong CY, Figueroa J, Tobin JR, Eisenach JC: Location and characteristics of nitric oxide synthase in sheep spinal cord and its interaction with alpha(2)- adrenergic and cholinergic antinociception. ANESTHESIOLOGY 1996; 84:890-9
44. Rady J, Fujimoto J: Spinal GABA receptors mediate brain delta opioid analgesia in Swiss Webster mice. Pharmacol Biochem Behav 1995; 51:655-9
45. Stamford J. Descending control of pain. Br J Anaesth 1995; 75:217-27
46. Renno W, Mullett M, Beitz A: Systemic morphine reduces GABA release in the lateral but not the medial portion of the midbrain periaqueductal gray of the rat. Brain Res 1992; 594:221-32
47. Kiefel J, Rossi G, Bodnar R: Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res 1993; 624:151-61
48. Lovick TA, Key BJ: Inhibitory effect of nitric oxide on neuronal activity in the periaqueductal grey matter of the rat. Exp Brain Res 1996; 108:382-8
49. Heinricher M, Tortorici V: Interference with GABA transmission in the rostral ventromedial medulla: Disinhibition of off-cells as a central mechanism in nociceptive modulation. Neuroscience 1994; 63:533-46
50. Raffa RB, Martinez RP: The 'glibenclamide-shift' of centrally- acting antinociceptive agents in mice. Brain Res 1995; 677:277-82